613 related articles for article (PubMed ID: 29249361)
1. Pharmacogenomics of GPCR Drug Targets.
Hauser AS; Chavali S; Masuho I; Jahn LJ; Martemyanov KA; Gloriam DE; Babu MM
Cell; 2018 Jan; 172(1-2):41-54.e19. PubMed ID: 29249361
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of the G protein-coupled receptors.
Thompson MD; Cole DE; Capra V; Siminovitch KA; Rovati GE; Burnham WM; Rana BK
Methods Mol Biol; 2014; 1175():189-242. PubMed ID: 25150871
[TBL] [Abstract][Full Text] [Related]
3. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.
Saikia S; Bordoloi M; Sarmah R
Curr Drug Targets; 2019; 20(5):522-539. PubMed ID: 30394207
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity.
Smit MJ; Vischer HF; Bakker RA; Jongejan A; Timmerman H; Pardo L; Leurs R
Annu Rev Pharmacol Toxicol; 2007; 47():53-87. PubMed ID: 17029567
[TBL] [Abstract][Full Text] [Related]
5. G protein-coupled receptor pharmacogenetics.
Thompson MD; Siminovitch KA; Cole DE
Methods Mol Biol; 2008; 448():139-85. PubMed ID: 18370234
[TBL] [Abstract][Full Text] [Related]
6. G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Sriram K; Insel PA
Mol Pharmacol; 2018 Apr; 93(4):251-258. PubMed ID: 29298813
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in G-protein-coupled receptors--consequences for G-protein-coupled receptors as drug targets.
Tang CM; Insel PA
Expert Opin Ther Targets; 2005 Dec; 9(6):1247-65. PubMed ID: 16300474
[TBL] [Abstract][Full Text] [Related]
8. G protein-coupled receptor accessory proteins and signaling: pharmacogenomic insights.
Thompson MD; Cole DE; Jose PA; Chidiac P
Methods Mol Biol; 2014; 1175():121-52. PubMed ID: 25150869
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease.
Thompson MD; Cole DE; Jose PA
Methods Mol Biol; 2008; 448():77-107. PubMed ID: 18370232
[TBL] [Abstract][Full Text] [Related]
10. Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges.
Johnson JA; Lima JJ
Pharmacogenetics; 2003 Sep; 13(9):525-34. PubMed ID: 12972951
[TBL] [Abstract][Full Text] [Related]
11. Chemogenomics approaches to G-protein coupled receptor lead finding.
Klabunde T; Jäger R
Ernst Schering Res Found Workshop; 2006; (58):31-46. PubMed ID: 16708997
[TBL] [Abstract][Full Text] [Related]
12. Utilization of Biased G Protein-Coupled ReceptorSignaling towards Development of Safer andPersonalized Therapeutics.
Ilter M; Mansoor S; Sensoy O
Molecules; 2019 May; 24(11):. PubMed ID: 31146474
[TBL] [Abstract][Full Text] [Related]
13. The G protein-coupled receptors: pharmacogenetics and disease.
Thompson MD; Burnham WM; Cole DE
Crit Rev Clin Lab Sci; 2005; 42(4):311-92. PubMed ID: 16281738
[TBL] [Abstract][Full Text] [Related]
14. Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells.
Stoeber M; Jullié D; Li J; Chakraborty S; Majumdar S; Lambert NA; Manglik A; von Zastrow M
Elife; 2020 Feb; 9():. PubMed ID: 32096468
[TBL] [Abstract][Full Text] [Related]
15. Beyond the Ligand: Extracellular and Transcellular G Protein-Coupled Receptor Complexes in Physiology and Pharmacology.
Dunn HA; Orlandi C; Martemyanov KA
Pharmacol Rev; 2019 Oct; 71(4):503-519. PubMed ID: 31515243
[TBL] [Abstract][Full Text] [Related]
16. GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors.
Sriram K; Moyung K; Corriden R; Carter H; Insel PA
PLoS Biol; 2019 Nov; 17(11):e3000434. PubMed ID: 31765370
[TBL] [Abstract][Full Text] [Related]
17. GPCR NaVa database: natural variants in human G protein-coupled receptors.
Kazius J; Wurdinger K; van Iterson M; Kok J; Bäck T; Ijzerman AP
Hum Mutat; 2008 Jan; 29(1):39-44. PubMed ID: 17924574
[TBL] [Abstract][Full Text] [Related]
18. G protein-coupled receptors disrupted in human genetic disease.
Thompson MD; Percy ME; McIntyre Burnham W; Cole DE
Methods Mol Biol; 2008; 448():109-37. PubMed ID: 18370233
[TBL] [Abstract][Full Text] [Related]
19. G Protein-Coupled Receptor (GPCR) Expression in Native Cells: "Novel" endoGPCRs as Physiologic Regulators and Therapeutic Targets.
Insel PA; Wilderman A; Zambon AC; Snead AN; Murray F; Aroonsakool N; McDonald DS; Zhou S; McCann T; Zhang L; Sriram K; Chinn AM; Michkov AV; Lynch RM; Overland AC; Corriden R
Mol Pharmacol; 2015 Jul; 88(1):181-7. PubMed ID: 25737495
[TBL] [Abstract][Full Text] [Related]
20. Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype.
Cornwell AC; Feigin ME
Trends Pharmacol Sci; 2020 Dec; 41(12):1006-1022. PubMed ID: 33198923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
